Vanda Pharmaceuticals Inc. (VNDA)

NGM – Real Time Price. Currency in USD

5.16

+0.23 (4.67%)

Market open: Aug 12, 2026, 3:46 PM EDT

5.02

+0.09 (1.83%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

216M

199M

193M

254M

Cost of goods sold

-20M

-19M

-17M

-26M

Gross Profit

196M

180M

176M

229M

Operating expenses (excl. COGS)

-347M

-221M

-190M

-222M

Operating Income

-151M

-41M

-14M

Non-operating income, total

13M

18M

20M

Pretax income

-139M

-23M

11M

Equity in earnings

Taxes

-82M

-4M

-5M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-220M

-19M

Discontinued operations

Net income

-220M

-19M

Dilution adjustment

Preferred dividends

Vanda Pharmaceuticals Inc. (VNDA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vanda Pharmaceuticals Inc. (VNDA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Vanda Pharmaceuticals Inc. (VNDA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vanda Pharmaceuticals Inc. (VNDA)

Income Statement (Annual)

Income Statement (Annual)